13F filer · CIK 1388551
CAXTON CORP
Princeton, NJ · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$1.9M
$-2.2M vs prior
Positions
10
New / sold out
4 / 1
Added / reduced
2 / 1
Turnover
38.8%
buys $1.1M · sells $3.3M
Top-10 weight
100.0%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | SPACE EXPLORATION TECHN CORP | +2,606 | – | +$445.3K |
| New | ALPHABET INC | +691 | – | +$246.9K |
| New | VANGUARD INDEX FDS | +339 | – | +$233.1K |
| New | BLACKSTONE INC | +1,597 | – | +$188.2K |
| Added | LEXEO THERAPEUTICS INC | +3,019 | +21.7% | +$14.1K |
| Added | BERKSHIRE HATHAWAY INC DEL | +27 | +3.7% | +$13.5K |
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | SPDR GOLD TR | -7,623 | -100.0% | $-3.3M |
| Reduced | KYVERNA THERAPEUTICS INC | -6,426 | -34.2% | $-57.3K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | SPACE EXPLORATION TECHN CORPPUT | 2,606 | $445.3K | 24.03% |
| 2 | BERKSHIRE HATHAWAY INC DELCL B NEW | 754 | $377.1K | 20.35% |
| 3 | ALPHABET INCCAP STK CL A | 691 | $246.9K | 13.32% |
| 4 | VANGUARD INDEX FDSS&P 500 ETF SHS | 339 | $233.1K | 12.58% |
| 5 | BLACKSTONE INCCOM | 1,597 | $188.2K | 10.16% |
| 6 | KYVERNA THERAPEUTICS INCCOM | 12,347 | $110.0K | 5.94% |
| 7 | LEXEO THERAPEUTICS INCCOM | 16,962 | $79.0K | 4.26% |
| 8 | X4 PHARMACEUTICALS INCCOM NEW | 15,557 | $72.7K | 3.92% |
| 9 | INHIBIKASE THERAPEUTICS INCCOM NEW | 28,453 | $57.8K | 3.12% |
| 10 | ALX ONCOLOGY HLDGS INCCOM | 20,946 | $43.4K | 2.34% |